Sunflower meal (SFM) is regarded as a promising substitute for FM and a cost-effective supply of essential nutrients
N Engl J Med 369(4):330340 Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Gali N et al (2015) Selexipag for the Treatment of Pulmonary Arterial Hypertension
Reaction-based fluorescent probes for the detection and imaging of reactive oxygen, nitrogen, and sulfur species
Densifying lignocellulosic biomass with alkaline chemicals (DLC) pretreatment unlocks highly fermentable sugars for bioethanol production from corn stover

Higher dose exploration (4.5mg trials) Rationale for testing 4.5mg: Investigate maximum tolerable dose Determine if higher = better weight loss Establish safety ceiling Results at 4.5mg weekly: Weight loss: ~12% (vs 10% at 2.4mg) Incremental benefit: Only 2% additional loss Side effects: Significantly worse nausea/vomiting Dropout rate: Higher than 2.4mg Clinical verdict: 4.5mg not recommended for routine use Risk-benefit ratio unfavorable 2.4mg remains optimal Some individuals may tolerate 3.0mg as compromise CagriSema combination dosing trials REDEFINE-1 protocol: Semaglutide: 2.4mg weekly (standard titration over 16 weeks) Cagrilintide: 2.4mg weekly (12-week titration) Both given as separate injections Started simultaneously from week 1 Semaglutide escalation (standard): Weeks 1-4: 0.25mg Weeks 5-8: 0.5mg Weeks 9-12: 1.0mg Weeks 13-16: 1.7mg Week 17+: 2.4mg Cagrilintide escalation (when combined): Weeks 1-4: 0.6mg Weeks 5-8: 1.2mg Weeks 9-12: 1.8mg Week 13+: 2.4mg Results: 15.6% average weight loss (68 weeks) Superior to either alone Side effects manageable with slow titration Combination well-tolerated See our cagrilintide and semaglutide combination guide and semaglutide dosage calculator

Common Questions From Researchers Many labs ask us, Can I store my peptides for longer if I add more bac water? The answer: not really